JointHealth
français
 
JointHealth™ express   November 8, 2013


How much do you know about SEBs?

Subsequent-entry biologics (SEBs) Survey for people in Ontario.

Arthritis Consumer Experts (ACE) wants to know your views on subsequent-entry biologics (SEBs) and learn how much you know about them. Help ACE help you be completing this short survey.

Health Canada defines SEBS as a “biologic drug that enters the market subsequent to a version previously authorized in Canada, and with demonstrated similarity to a reference biologic drug.” Unlike generic medications, SEBs are not identical to their originator drugs. Since every biologic is made from living cells, even minor differences from the originator drug change the way a SEB acts in the body.

Your feedback is vitally important to the work ACE conducts on behalf of the more than 1.8 million people in Ontario living with arthritis.

Please take 10-15 minutes to fill out this survey. Please be assured that all responses will remain anonymous and confidential. Personal information will not be collected as part of this survey.